🔎 Trials Near Me

Home › Cancer sa Matris › Ohio

Pag-aaral pangklinika para sa Cancer sa Matris sa Ohio

6 pag-aaral para sa Cancer sa Matris ang naghahanap ng mga kalahok sa mga site sa Ohio.

Mga Lungsod sa Ohio

Opisyal na teksto ng pag-aaral (English)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • Miami Valley Hospital South, Centerville
  • SCC at UH Geauga Medical Center, Chardon
  • University Hospitals Cleveland Medical Center, Cleveland
  • at 12 pa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Cincinnati
  • Research Site, Columbus
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112

Investigations of Reproductive Cancers in Women

  • Summa Health, Akron
  • The Ohio State University, Columbus
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 100 · Kababaihan · Na-update Ago 17, 2026 · NCT06527157

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Cincinnati
  • Research Site, Cleveland
  • Research Site, Cleveland
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Nationwide Children's Hospital, Colombus
  • The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
  • Taylor Cancer Research Center, Maumee
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.